Oxidant/Antioxidant Imbalance in Alzheimer’s Disease: Therapeutic and Diagnostic Prospects

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families

Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · see citing works

Aging: a theory based on free radical and radiation chemistry

Harman, D. (1956) · Journal of Gerontology · doi:10.1093/geronj/11.3.298 · Cited by 8,567 · see citing works

How mitochondria produce reactive oxygen species

Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207 · see citing works

Alzheimer's disease: the amyloid cascade hypothesis

Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · see citing works

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease

Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155 · see citing works

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · see citing works

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051 · see citing works

Oxidative Stress, Glutamate, and Neurodegenerative Disorders

Coyle, J. T., & Puttfarcken, P. (1993) · Science · doi:10.1126/science.7901908 · Cited by 3,762 · see citing works

Oxidative Stress

Sies, H., Berndt, C., & Jones, D. P. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-045037 · Cited by 3,520 · see citing works

Neuropathological alterations in Alzheimer disease

Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345 · see citing works

Oxidative stress: a concept in redox biology and medicine

Sies, H. (2015) · Redox Biology · doi:10.1016/j.redox.2015.01.002 · Cited by 3,015 · see citing works

Alzheimer disease in the United States (2010–2050) estimated using the 2010 census

Hebert, L. E., Weuve, J., Scherr, P. A., & Evans, D. A. (2013) · Neurology · doi:10.1212/wnl.0b013e31828726f5 · Cited by 2,642 · see citing works

Glutathione: overview of its protective roles, measurement, and biosynthesis

Forman, H. J., Zhang, H., & Rinna, A. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.08.006 · Cited by 2,636 · see citing works

Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality

Miller, E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00110 · Cited by 2,577 · see citing works

Oxidative stress hypothesis in Alzheimer’s disease

Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383 · see citing works

Brain energy metabolism: focus on Astrocyte-neuron metabolic cooperation

Bélanger, M., Allaman, I., & Magistretti, P. J. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.016 · Cited by 2,313 · see citing works

Glutathione synthesis

Lu, S. C.-L. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.09.008 · Cited by 2,192 · see citing works

Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene

Rogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., et al. (1995) · Nature · doi:10.1038/376775a0 · Cited by 2,052 · see citing works

RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease

Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012 · see citing works

Oxidative Damage Is the Earliest Event in Alzheimer Disease

Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885 · see citing works

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

Brookmeyer, R., Gray, S. G., & Kawas, C. H. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,774 · see citing works

A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

Jonsson, T., Atwal, J. K., Steinberg, S., Snaedal, J., Jonsson, P. V., Bjornsson, S., Stefansson, H., Sulem, P., Gudbjartsson, D., Maloney, J., et al. (2012) · Nature · doi:10.1038/nature11283 · Cited by 1,738 · see citing works

Redefining Oxidative Stress

Jones, D. P. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1865 · Cited by 1,726 · see citing works

Aging, energy, and oxidative stress in neurodegenerative diseases

Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,434 · see citing works

Mitochondrial abnormalities in Alzheimer's disease

Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367 · see citing works

Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins

Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y., Pinsky, D. J., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,305 · see citing works

ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease

Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., et al. (2004) · Science · doi:10.1126/science.1091230 · Cited by 1,303 · see citing works

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.

Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296 · see citing works

Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus

Tangvarasittichai, S. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i3.456 · Cited by 1,236 · see citing works

Dietary Intake of Antioxidants and Risk of Alzheimer Disease

Engelhart, M. J. (2002) · JAMA · doi:10.1001/jama.287.24.3223 · Cited by 1,080 · see citing works

Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease

Mecocci, P., MacGarvey, U., & Beal, M. F. (1994) · Annals of Neurology · doi:10.1002/ana.410360510 · Cited by 1,037 · see citing works

[ ¹¹ C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease

Mintun, M. A., LaRossa, G. N., Sheline, Y. I., Dence, C. S., Lee, S. Y., Mach, R. H., Klunk, W. E., Mathis, C. A., DeKosky, S. T., & Morris, J. C. (2006) · Neurology · doi:10.1212/01.wnl.0000228230.26044.a4 · Cited by 1,036 · see citing works

Metabolism and function of coenzyme Q

Turunen, M., Olsson, J., & Dallner, G. (2004) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2003.11.012 · Cited by 1,026 · see citing works

Apolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptides

Miyata, M., & Smith, J. D. (1996) · Nature Genetics · doi:10.1038/ng0996-55 · Cited by 889 · see citing works

Amyloid-β overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins

Wang, X., Su, B., Siedlak, S. L., Moreira, P. I., Fujioka, H., Wang, Y., Casadesus, G., & Zhu, X. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804871105 · Cited by 835 · see citing works

Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage

Mańczak, M., Calkins, M. J., & Reddy, P. H. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr139 · Cited by 830 · see citing works

Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: Implications for Alzheimer’s disease

Ebneth, A., Godemann, R., Stamer, K., Illenberger, S., Trinczek, B., Mandelkow, E.-M., & Mandelkow, E. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.3.777 · Cited by 820 · see citing works

Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications

Liu, Z., Zhou, T., Ziegler, A. C., Dimitrion, P., & Zuo, L. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2525967 · Cited by 810 · see citing works

How increased oxidative stress promotes longevity and metabolic health: The concept of mitochondrial hormesis (mitohormesis)

Ristow, M., & Zarse, K. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.03.014 · Cited by 789 · see citing works

Oxidative Alterations in Alzheimer's Disease

Markesbery, W. R., & Carney, J. M. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00215.x · Cited by 789 · see citing works

The Alzheimer’s disease mitochondrial cascade hypothesis: progress and perspectives

Swerdlow, R. H., Burns, J. M., & Khan, S. M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.010 · Cited by 786 · cited 1× · see citing works

Expression of Nrf2 in Neurodegenerative Diseases

Ramsey, C. P., Glass, C. A., Montgomery, M. B., Lindl, K. A., Ritson, G. P., Chia, L. A., Hamilton, R. L., Chu, C. T., & Jordan-Sciutto, K. L. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31802d6da9 · Cited by 760 · see citing works

A “mitochondrial cascade hypothesis” for sporadic Alzheimer’s disease

Swerdlow, R. H., & Khan, S. M. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2003.12.045 · Cited by 758 · see citing works

Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain

Mecocci, P., MacGarvey, U., Kaufman, A. E., Koontz, D., Shoffner, J. M., Wallace, D. C., & Beal, M. F. (1993) · Annals of Neurology · doi:10.1002/ana.410340416 · Cited by 757 · see citing works

An Important Role of Nrf2-ARE Pathway in the Cellular Defense Mechanism

Lee, J., & Johnson, J. A. (2004) · BMB Reports · doi:10.5483/bmbrep.2004.37.2.139 · Cited by 746 · see citing works

Long live FOXO : unraveling the role of FOXO proteins in aging and longevity

Martins, R., Lithgow, G. J., & Link, W. (2015) · Aging Cell · doi:10.1111/acel.12427 · Cited by 728 · see citing works

Delivery of bioactive molecules to mitochondria <i>in</i> <i>vivo</i>

Smith, R. A. J., Porteous, C. M., Gane, A. M., & Murphy, M. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931245100 · Cited by 725 · see citing works

Extending life span by increasing oxidative stress

Ristow, M., & Schmeisser, S. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.010 · Cited by 718 · see citing works

APOLIPOPROTEIN E ALLELES AS RISK FACTORS IN ALZHEIMER'S DISEASE

Roses, M. D. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.387 · Cited by 707 · see citing works

Dietary Intake of Antioxidant Nutrients and the Risk of Incident Alzheimer Disease in a Biracial Community Study

Morris, M. C. (2002) · JAMA · doi:10.1001/jama.287.24.3230 · Cited by 678 · see citing works

Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease

Calkins, M. J., Manczak, M., Mao, P., Shirendeb, U., & Reddy, P. H. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr381 · Cited by 646 · see citing works

Oxidative stress in the progression of Alzheimer disease in the frontal cortex

Ansari, M. A., & Scheff, S. W. (2010) · Journal of Neuropathology &amp; Experimental Neurology · doi:10.1097/nen.0b013e3181cb5af4 · Cited by 605 · see citing works

Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson’s disease and Alzheimer’s disease

Jiang, T., Sun, Q., & Chen, S. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.07.005 · Cited by 594 · see citing works

β-Amyloid Peptides Induce Mitochondrial Dysfunction and Oxidative Stress in Astrocytes and Death of Neurons through Activation of NADPH Oxidase

Abramov, A. Y., Canevari, L., & Duchen, M. R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4042-03.2004 · Cited by 587 · see citing works

The Alzheimer’s Disease Mitochondrial Cascade Hypothesis

Swerdlow, R. H., Burns, J. M., & Khan, S. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100339 · Cited by 562 · see citing works

On the path to 2025: understanding the Alzheimer’s disease continuum

Aisen, P. S., Cummings, J., Jack, C. R., Morris, J. C., Sperling, R., Frölich, L., Jones, R. W., Dowsett, S. A., Matthews, B. R., Raskin, J., et al. (2017) · Alzheimer's Research &amp; Therapy · doi:10.1186/s13195-017-0283-5 · Cited by 556 · see citing works

Comprehensive Insights into the Multi-Antioxidative Mechanisms of Melanin Nanoparticles and Their Application To Protect Brain from Injury in Ischemic Stroke

Liu, Y., Ai, K., Ji, X., Askhatova, D., Du, R., Lu, L., & Shi, J. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b11013 · Cited by 548 · see citing works

Linking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis

Small, S. A., & Duff, K. (2008) · Neuron · doi:10.1016/j.neuron.2008.11.007 · Cited by 546 · see citing works

Neurotoxicity of Alzheimer’s disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio

Kuperstein, I., Broersen, K., Benilova, I., Rozenski, J., Jonckheere, W., Debulpaep, M., Vandersteen, A., Segers‐Nolten, I., Van Der Werf, K., Subramaniam, V., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.211 · Cited by 532 · see citing works

γ-Secretase: Successive Tripeptide and Tetrapeptide Release from the Transmembrane Domain of β-Carboxyl Terminal Fragment

Takami, M., Nagashima, Y., Sano, Y., Ishihara, S., Morishima-Kawashima, M., Funamoto, S., & Ihara, Y. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2362-09.2009 · Cited by 498 · see citing works

Tau Reduction Prevents Aβ-Induced Defects in Axonal Transport

Vossel, K. A., Zhang, K., Brodbeck, J., Daub, A. C., Sharma, P., Finkbeiner, S., Cui, B., & Mucke, L. (2010) · Science · doi:10.1126/science.1194653 · Cited by 486 · see citing works

β‐Amyloid inhibits integrated mitochondrial respiration and key enzyme activities

Casley, C. S., Canevari, L., Land, J. M., Clark, J. B., & Sharpe, M. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00681.x · Cited by 485 · see citing works

Increased Nuclear DNA Oxidation in the Brain in Alzheimer's Disease

Gabbita, S. P., Lovell, M. A., & Markesbery, W. R. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71052034.x · Cited by 479 · see citing works

A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients

Maurer, I. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00112-3 · Cited by 475 · see citing works

Mitochondria-targeted antioxidants protect against amyloid-β toxicity in Alzheimer's disease neurons

Manczak, M., Mao, P., Calkins, M. J., Cornea, A., Reddy, A. P., Murphy, M. P., Szeto, H. H., Park, B., & Reddy, P. H. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100564 · Cited by 469 · see citing works

Selective targeting of an antioxidant to mitochondria

Smith, R. A. J., Porteous, C. M., Coulter, C. V., & Murphy, M. P. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00543.x · Cited by 466 · see citing works

Glucose and reactive oxygen species

Bonnefont‐Rousselot, D. (2002) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200209000-00016 · Cited by 455 · see citing works

Environmental risk factors for dementia: a systematic review

Killin, L. O. J., Starr, J. M., Shiue, I., & Russ, T. C. (2016) · BMC Geriatrics · doi:10.1186/s12877-016-0342-y · Cited by 442 · see citing works

Regional Membrane Phospholipid Alterations in Alzheimer's Disease

Prasad, M. R., Lovell, M. A., Yatin, M., Dhillon, H. S., & Markesbery, W. R. (1998) · Neurochemical Research · doi:10.1023/a:1022457605436 · Cited by 440 · see citing works

Unraveling the Truth About Antioxidants: Mitohormesis explains ROS-induced health benefits

Ristow, M. (2014) · Nature Medicine · doi:10.1038/nm.3624 · Cited by 417 · cited 1× · see citing works

Mitochondrial Diseases of the Brain

Chaturvedi, R. K., & Beal, M. F. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.03.018 · Cited by 416 · see citing works

Apolipoprotein E in Alzheimer's Disease: An Update

Yu, J.-T., Tan, L., & Hardy, J. (2014) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071013-014300 · Cited by 394 · see citing works

Tau Promotes Neurodegeneration via DRP1 Mislocalization In Vivo

DuBoff, B., Götz, J., & Feany, M. B. (2012) · Neuron · doi:10.1016/j.neuron.2012.06.026 · Cited by 377 · see citing works

Antioxidants for Alzheimer Disease: A Randomized Clinical Trial With Cerebrospinal Fluid Biomarker Measures

Galasko, D. R., Peskind, E., Clark, C. M., Quinn, J. F., Ringman, J. M., Jicha, G. A., Cotman, C., Cottrell, B., Montine, T. J., Thomas, R. G., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.85 · Cited by 377 · see citing works

Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative

Gabuzda, D., Busciglio, J., Chen, L. B., Matsudaira, P., & Yankner, B. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36875-8 · Cited by 373 · see citing works

Mitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation

Leuner, K., Schütt, T., Kurz, C., Eckert, S. H., Schiller, C., Occhipinti, A., Mai, S., Jendrach, M., Eckert, G. P., Kruse, S. E., et al. (2012) · Antioxidants &amp; Redox Signaling · doi:10.1089/ars.2011.4173 · Cited by 354 · see citing works

Metallostasis in Alzheimer's disease

Ayton, S., Lei, P., & Bush, A. I. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.10.558 · Cited by 354 · see citing works

Expression of heme oxygenase‐1 in the senescent and alzheimer‐diseased brain

Schipper, H. M., Cissé, S., & Stopa, E. G. (1995) · Annals of Neurology · doi:10.1002/ana.410370609 · Cited by 353 · see citing works

Abnormalities of mitochondrial enzymes in Alzheimer disease

Gibson, G. E., Sheu, K.-F. R., & Blass, J. P. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050099 · Cited by 345 · see citing works

Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease

Resende, R., Moreira, P. I., Proença, T., Deshpande, A., Busciglio, J., Pereira, C., & Oliveira, C. R. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.03.012 · Cited by 343 · see citing works

Dynamin-Like Protein 1 Reduction Underlies Mitochondrial Morphology and Distribution Abnormalities in Fibroblasts from Sporadic Alzheimer's Disease Patients

Wang, X., Su, B., Fujioka, H., & Zhu, X. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.071208 · Cited by 341 · see citing works

Brain Glutathione Levels – A Novel Biomarker for Mild Cognitive Impairment and Alzheimer’s Disease

Mandal, P. K., Saharan, S., Tripathi, M., & Murari, G. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.04.005 · Cited by 339 · see citing works

Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects

Vassar, R., Kuhn, P.-H., Haass, C., Kennedy, M. E., Rajendran, L., Wong, P. C., & Lichtenthaler, S. F. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12715 · Cited by 333 · see citing works

Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications

Cracowski, J., Durand, T., & Bessard, G. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02053-9 · Cited by 330 · see citing works

Association of Antioxidant Supplement Use and Dementia in the Prevention of Alzheimer’s Disease by Vitamin E and Selenium Trial (PREADViSE)

Kryscio, R. J., Abner, E. L., Caban‐Holt, A., Lovell, M. A., Goodman, P. J., Darke, A. K., Yee, M., Crowley, J. J., & Schmitt, F. A. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.5778 · Cited by 298 · see citing works

Lessons Learned from Alzheimer Disease: Clinical Trials with Negative Outcomes

Cummings, J. (2018) · Clinical and Translational Science · doi:10.1111/cts.12491 · Cited by 298 · see citing works

Role of RAGE in Alzheimer’s Disease

Cai, Z., Liu, N., Wang, C., Qin, B., Zhou, Y., Xiao, M., Chang, L., Yan, L., & Zhao, B. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0233-3 · Cited by 286 · see citing works

Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond

Cuyvers, E., & Sleegers, K. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00127-7 · Cited by 284 · see citing works

Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A 2 in cortical neurons

Shelat, P. B., Chalimoniuk, M., Wang, J., Strosznajder, J. B., Lee, J. C., Sun, A. Y., Simonyi, Á., & Sun, G. Y. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05347.x · Cited by 283 · see citing works

Resveratrol for Alzheimer's disease

Sawda, C. N., Moussa, C., & Turner, R. S. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13431 · Cited by 281 · see citing works

Potential roles of insulin and IGF-1 in Alzheimer's disease

Gasparini, L., & Xu, H. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00163-2 · Cited by 275 · see citing works

Cerium oxide nanoparticles scavenge nitric oxide radical (˙NO)

Dowding, J. M., Dosani, T., Kumar, A., et al. (2012) · Chemical Communications · doi:10.1039/c2cc30485f · Cited by 272 · see citing works

Heme oxygenase-1: role in brain aging and neurodegeneration

Schipper, H. M. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00148-0 · Cited by 269 · see citing works

A mitochondria-targeted nitroxide is reduced to its hydroxylamine by ubiquinol in mitochondria

Trnka, J., Blaikie, F. H., Smith, R. A. J., & Murphy, M. P. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.12.036 · Cited by 262 · see citing works

Decrease in Peptide Methionine Sulfoxide Reductase in Alzheimer's Disease Brain

Gabbita, S. P., Aksenov, M. Y., Lovell, M. A., & Markesbery, W. R. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731660.x · Cited by 256 · see citing works

Increased CSF F 2 -isoprostane concentration in probable AD

Montine, T. J., Beal, M. F., Cudkowicz, M., O’Donnell, H., Margolin, R. A., McFarland, L. L., Bachrach, A., Zackert, W. E., Roberts, L. J., & Morrow, J. D. (1999) · Neurology · doi:10.1212/wnl.52.3.562 · Cited by 251 · see citing works

Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons

Calkins, M. J., & Reddy, P. H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.01.007 · Cited by 244 · see citing works

Genetic mouse models of brain ageing and Alzheimer's disease

Bilkei‐Gorzó, A. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.12.009 · Cited by 244 · see citing works

Redox-Dependent Modulation of Aconitase Activity in Intact Mitochondria

Bulteau, A.-L., Ikeda-Saito, M., & Szweda, L. I. (2003) · Biochemistry · doi:10.1021/bi0353979 · Cited by 241 · see citing works

Redox Regulation of Cellular Stress Response in Aging and Neurodegenerative Disorders: Role of Vitagenes

Calabrese, V., Guagliano, E., Sapienza, M. A., Panebianco, M., Calafato, S., Puleo, E., Pennisi, G., Mancuso, C., Butterfield, D. A., & Stella, A. G. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9203-y · Cited by 241 · see citing works

Controlled trial of N-acetylcysteine for patients with probable Alzheimer’s disease

Adair, J. C., Knoefel, J. E., & Morgan, N. (2001) · Neurology · doi:10.1212/wnl.57.8.1515 · Cited by 240 · see citing works

Alterations of plasma magnesium, copper, zinc, iron and selenium concentrations and some related erythrocyte antioxidant enzyme activities in patients with Alzheimer’s disease

Vural, H., Demirin, H., Kara, Y. B., Eren, İ., & Delibaş, N. (2010) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2010.02.002 · Cited by 235 · see citing works

Nitrosative Stress, Cellular Stress Response, and Thiol Homeostasis in Patients with Alzheimer's Disease

Calabrese, V., Rukhsana Sultana, A., Scapagnini, G., Guagliano, E., Sapienza, M. A., Bella, R., Kański, J., Pennisi, G., Mancuso, C., Stella, A. M. G., et al. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.1975 · Cited by 227 · see citing works

Vitamin E Paradox in Alzheimer's Disease: It Does Not Prevent Loss of Cognition and May Even Be Detrimental

Lloret, A., Badía, M.-C., Mora, N. J., Pallardó, F. V., Alonso, M.-D., & Viña, J. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1033 · Cited by 222 · see citing works

Cerium oxide nanoparticles protect against Aβ-induced mitochondrial fragmentation and neuronal cell death

Dowding, J. M., Song, W., Bossy, K., Karakoti, A., Kumar, A., Kim, A., Bossy, B., Seal, S., Ellisman, M. H., Perkins, G., et al. (2014) · Cell Death &amp; Differentiation · doi:10.1038/cdd.2014.72 · Cited by 221 · see citing works

Inhibition of the Mitochondrial Permeability Transition by Creatine Kinase Substrates

Dolder, M., Walzel, B., Speer, O., Schlattner, U., & Wallimann, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208705200 · Cited by 219 · see citing works

Oxidative stress potentiates BACE1 gene expression and A? generation

Tong, Y., Zhou, W., Fung, V., Christensen, M. A., Qing, H., Sun, X., & Song, W. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0255-3 · Cited by 218 · see citing works

Mitochondrial membrane fluidity and oxidative damage to mitochondrial DNA in aged and AD human brain

Mecocci, P., Beal, M. F., Cecchetti, R., Polidori, M. C., Cherubini, A., Chionne, F., Avellini, L., Romano, G., & Senin, U. (1997) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815160 · Cited by 215 · see citing works

Mitochondrial Dysfunction: Different Routes to Alzheimer’s Disease Therapy

Picone, P., Nuzzo, D., Caruana, L., Scafidi, V., & Carlo, M. D. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/780179 · Cited by 208 · see citing works

Clinical Aspects of Melatonin Intervention in Alzheimers Disease Progression

Cardinali, D. P., Furio, A. M., & Brusco, L. I. (2010) · Current Neuropharmacology · doi:10.2174/157015910792246209 · Cited by 207 · see citing works

β-Amyloid Fragment 25–35 Causes Mitochondrial Dysfunction in Primary Cortical Neurons

Casley, C. S., Land, J. M., Sharpe, M. A., Clark, J. B., Duchen, M. R., & Canevari, L. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0516 · Cited by 205 · see citing works

Decreased thioredoxin and increased thioredoxin reductase levels in alzheimer’s disease brain

Lovell, M. A., Xie, C., Gabbita, S. P., & Markesbery, W. R. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00258-0 · Cited by 202 · see citing works

Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment

Schipper, H. M., BENNETT, D., Liberman, A., Bienias, J. L., Schneider, J. A., Kelly, J. W., & Arvanitakis, Z. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.01.016 · Cited by 199 · see citing works

β‐Amyloid fragment 25–35 selectively decreases complex IV activity in isolated mitochondria

Canevari, L., Clark, J. B., & Bates, T. E. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01028-5 · Cited by 196 · see citing works

Oxidative Insults Are Associated with Apolipoprotein E Genotype in Alzheimer's Disease Brain

Ramassamy, C., Averill‐Bates, D. A., Beffert, U., Théroux, L., Lussier‐Cacan, S., Cohn, J. S., Christen, Y., Schoofs, A. R., Davignon, J., & Poirier, J. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0273 · Cited by 194 · see citing works

In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid β-peptide of APP

Butterfield, D. A., Galván, V., Lange, M. L. B., Tang, H., Robinson, R. A. S., Spilman, P. R., Fombonne, J., Gorostiza, O. F., Zhang, J., Rukhsana Sultana, A., et al. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.10.035 · Cited by 188 · see citing works

Mitochondrial alterations near amyloid plaques in an Alzheimer’s disease mouse model

Xie, H., Guan, J., Borrelli, L. A., Xu, J., Serrano-Pozo, A., & Bacskai, B. J. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1836-13.2013 · Cited by 185 · cited 1× · see citing works

Oxidative stress involving changes in Nrf2 and ER stress in early stages of Alzheimer's disease

Mota, S. I., Costa, R. O., Ferreira, I. L., Santana, I., Caldeira, G. L., Padovano, C., Fonseca, A. C., Baldeiras, I., Cunha, C., Letra, L., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.03.015 · Cited by 183 · see citing works

Resveratrol and Alzheimer’s Disease: Mechanistic Insights

Ahmed, T., Javed, S., Javed, S., Tariq, A., Šamec, D., Tejada, S., Nabavi, S. F., Braidy, N., & Nabavi, S. M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9839-9 · Cited by 179 · see citing works

Plasma Selenium Over Time and Cognitive Decline in the Elderly

Akbaraly, T. N., Hininger‐Favier, I., re, I. C., Arnaud, J., Gourlet, V., Roussel, A., & Berr, C. (2006) · Epidemiology · doi:10.1097/01.ede.0000248202.83695.4e · Cited by 178 · see citing works

Effects of Vitamin E on Cognitive Performance during Ageing and in Alzheimer’s Disease

Fata, G. L., Weber, P., & Mohajeri, M. H. (2014) · Nutrients · doi:10.3390/nu6125453 · Cited by 174 · see citing works

AGE/RAGE produces endothelial dysfunction in coronary arterioles in Type 2 diabetic mice

Gao, X. J., Zhang, H., Schmidt, A. M., & Zhang, C. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00464.2008 · Cited by 174 · see citing works

Cognitive impairment and dementia: a new emerging complication of type 2 diabetes—The diabetologist’s perspective

Simó, R., Ciudin, A., Simó‐Servat, O., & Hernández, C. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-0970-5 · Cited by 172 · see citing works

Coenzyme Q10 as a therapy for mitochondrial disease

Hargreaves, I. P. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.01.020 · Cited by 170 · see citing works

Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment

Bermejo‐Bescós, P., Martín‐Aragón, S., Benedı́, J., Susín, C., Felici, E., Gil, P., Ribera, J. M., & Villar, Á. (2008) · Free Radical Research · doi:10.1080/10715760701861373 · Cited by 167 · see citing works

Oxidative damage to DNA in lymphocytes from AD patients

Mecocci, P., Polidori, M. C., Ingegni, T., Cherubini, A., Chionne, F., Cecchetti, R., & Senin, U. (1998) · Neurology · doi:10.1212/wnl.51.4.1014 · Cited by 166 · see citing works

Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment

Valla, J., Schneider, L., Niedzielko, T., Coon, K. D., Caselli, R., Sabbagh, M. N., Ahern, G. L., Baxter, L., Alexander, G., Walker, D. G., et al. (2006) · Mitochondrion · doi:10.1016/j.mito.2006.10.004 · Cited by 159 · see citing works

Peripheral Oxidative Damage in Mild Cognitive Impairment and Mild Alzheimer's Disease

Baldeiras, I., Santana, I. J., Proença, M. T., Garrucho, M. H., Pascoal, R., Rodrigues, A. P., Duro, D., & Oliveira, C. R. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15110 · Cited by 157 · see citing works

Tocopherols and tocotrienols plasma levels are associated with cognitive impairment

Mangialasche, F., Xu, W., Kivipelto, M., Costanzi, E., Ercolani, S., Pigliautile, M., Cecchetti, R., Baglioni, M., Simmons, A., Soininen, H. S., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.11.019 · Cited by 157 · see citing works

Oxidative stress and lipid peroxidation are upstream of amyloid pathology

Arimon, M., Takeda, S., Post, K. E., Svirsky, S. E., Hyman, B. T., & Berezovska, O. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.06.013 · Cited by 155 · see citing works

Unraveling the Truth About Antioxidants: ROS and disease: finding the right balance

Kawagishi, H., & Finkel, T. (2014) · Nature Medicine · doi:10.1038/nm.3625 · Cited by 152 · see citing works

Increased Autophagic Degradation of Mitochondria in Alzheimer Disease

Moreira, P. I., Siedlak, S. L., Wang, X., Santos, M. S., Oliveira, C. R., Tabaton, M., Nunomura, A., Szweda, L. I., Aliev, G. M., Smith, M. A., et al. (2007) · Autophagy · doi:10.4161/auto.4872 · Cited by 150 · see citing works

Linking Alzheimer's disease to insulin resistance: the FoxO response to oxidative stress

Manolopoulos, K. N., Klotz, L.-O., Korsten, P., Bornstein, S. R., & Barthel, A. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.17 · Cited by 150 · see citing works

Autophagocytosis of Mitochondria Is Prominent in Alzheimer Disease

Moreira, P. I., Siedlak, S. L., Wang, X., Santos, M. S., Oliveira, C. R., Tabaton, M., Nunomura, A., Szweda, L. I., Aliev, G. M., Smith, M. A., et al. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000240476.73532.b0 · Cited by 145 · see citing works

Genomics of Alzheimer Disease

Rosenberg, R. N., Lambracht‐Washington, D., Yu, G., & Xia, W. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.0301 · Cited by 145 · see citing works

Advances in Alzheimer’s Diagnosis and Therapy: The Implications of Nanotechnology

Hajipour, M. J., Santoso, M. R., Rezaee, F., Aghaverdi, H., Mahmoudi, M., & Perry, G. L. (2017) · Trends in biotechnology · doi:10.1016/j.tibtech.2017.06.002 · Cited by 143 · see citing works

The amyloid-beta forming tripeptide cleavage mechanism of γ-secretase

Bolduc, D. M., Montagna, D. R., Seghers, M., Wolfe, M. S., & Selkoe, D. J. (2016) · eLife · doi:10.7554/elife.17578 · Cited by 141 · see citing works

Heat shock proteins and hormesis in the diagnosis and treatment of neurodegenerative diseases

Dattilo, S., Mancuso, C., Koverech, G., Mauro, P. D., Ontario, M. L., Petralia, C. C. T., Petralia, A., Maiolino, L., Serra, A., Calabrese, E. J., et al. (2015) · Immunity & Ageing · doi:10.1186/s12979-015-0046-8 · Cited by 140 · see citing works

Curcumin and Resveratrol in the Management of Cognitive Disorders: What is the Clinical Evidence?

Mazzanti, G., & Giacomo, S. D. (2016) · Molecules · doi:10.3390/molecules21091243 · Cited by 130 · see citing works

Challenges associated with curcumin therapy in Alzheimer disease

Belkacemi, A., Doggui, S., Dao, L. H., & Ramassamy, C. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411002055 · Cited by 129 · see citing works

Peripheral Mitochondrial Dysfunction in Alzheimer’s Disease: Focus on Lymphocytes

Leuner, K., Schulz, K. L., Schuett, T., Pantel, J., Prvulovic, D., Rhein, V. F., Savaskan, E., Czech, C., Eckert, A., & Müller, W. E. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8300-y · Cited by 127 · see citing works

The 2013 SFRBM Discovery Award: Selected discoveries from the Butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment

Butterfield, D. A. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.006 · Cited by 126 · see citing works

A Controlled Study of 2 Doses of Idebenone in the Treatment of Alzheimer’s Disease

Weyer, G., Babej-Dölle, R. M., Hadler, D., Hofmann, S., & Herrmann, W. M. (2008) · Neuropsychobiology · doi:10.1159/000119366 · Cited by 120 · cited 1× · see citing works

Nanoparticles as potential clinical therapeutic agents in Alzheimer’s disease: focus on selenium nanoparticles

Nazıroğlu, M., Muhamad, S., & Pecze, L. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1324781 · Cited by 118 · see citing works

The Cerebrocortical Areas in Normal Brain Aging and in Alzheimer's Disease: Noticeable Differences in the Lipid Peroxidation Level and in Antioxidant Defense

Karelson, E., Bogdanović, N., Garlind, A., Winblad, B. G., Zilmer, K., Kullisaar, T., Vihalemm, T., Kairane, C., & Zilmer, M. (2001) · Neurochemical Research · doi:10.1023/a:1010942929678 · Cited by 114 · see citing works

Neurotoxicity and Oxidative Damage of Beta Amyloid 1–42 versus Beta Amyloid 1–40 in the Mouse Cerebral Cortex

Klein, A., Kowall, N. W., & Ferrante, R. J. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07845.x · Cited by 114 · see citing works

Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer’s disease

Choi, B.-R., Cho, W.-H., Kim, J., Lee, H. J., Chung, C., Jeon, W. K., & Han, J.-S. (2014) · Experimental &amp; Molecular Medicine · doi:10.1038/emm.2013.147 · Cited by 111 · see citing works

Increased Protein and Lipid Oxidative Damage in Mitochondria Isolated from Lymphocytes from Patients with Alzheimer's Disease: Insights into the Role of Oxidative Stress in Alzheimer's Disease and Initial Investigations into a Potential Biomarker for this Dementing Disorder

Sultana, R., Mecocci, P., Mangialasche, F., Cecchetti, R., Baglioni, M., & Butterfield, D. A. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-101425 · Cited by 111 · see citing works

The Impact of Vitamin E and Other Fat-Soluble Vitamins on Alzheimer´s Disease

Grimm, M. O. W., Mett, J., & Hartmann, T. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111785 · Cited by 108 · see citing works

Elevated levels of oxidative DNA damage in lymphocytes from patients with Alzheimer’s disease11Abbreviations used: AD, Alzheimer’s disease; Endo III, Endonuclease III; 8OHA, 8-hydroxyadenine; 8OHG, 8-hydroxyguanine; 8OHdG, 8-hydroxy-2′-deoxyguanosine; Fapy-Ade, 4,6-diamino-5-formamidopyrimidine; Fapy-Gua, 2,6,-diamino-4-hydroxy-5-formamidopyrimidine; Fpg, formamidopyrimidine glycosilase; H2O2, hydrogen-peroxide; .OH, hydroxyl radical; PBS, phosphate-buffered saline; ROS, reactive oxygen species; RT, room temperature; SSB, single strand break

Mórocz, M., Kalman, J. L., Juhász, A., Sinkó, I., McGlynn, A. P., Downes, C. S., Janka, Z., & Raskó, I. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00257-3 · Cited by 105 · see citing works

Interaction of misfolded proteins and mitochondria in neurodegenerative disorders

Abramov, A. Y., Berezhnov, A. V., Fedotova, E. I., Зинченко, В. П., & Долгачева, Л. П. (2017) · Biochemical Society Transactions · doi:10.1042/bst20170024 · Cited by 105 · see citing works

RAGE Expression and ROS Generation in Neurons: Differentiation versus Damage

Piras, S., Furfaro, A. L., Domenicotti, C., Traverso, N., Marinari, U. M., Pronzato, M. A., & Nitti, M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9348651 · Cited by 104 · see citing works

Detection of oxidative DNA damage in lymphocytes of patients with Alzheimer's disease

Kadıoğlu, E., Şardaş, S., Aslan, S., Işık, E., & Karakaya, A. E. (2004) · Biomarkers · doi:10.1080/13547500410001728390 · Cited by 103 · see citing works

Strategy to reduce free radical species in Alzheimer’s disease: an update of selected antioxidants

Domenico, F. D., Barone, E., Marzia Perluigi, A., & Butterfield, D. A. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.955853 · Cited by 102 · see citing works

Gluthatione level is altered in lymphoblasts from patients with familial Alzheimer’s disease

Cecchi, C., Latorraca, S., Sorbi, S., Iantomasi, T., Favilli, F., Vincenzini, M. T., & Liguri, G. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00751-x · Cited by 101 · see citing works

Oxidative lipid modification of nicastrin enhances amyloidogenic γ‐secretase activity in Alzheimer’s disease

Gwon, A., Park, J., Arumugam, T. V., Kwon, Y., Chan, S. L., Kim, S.-H., Baik, S., Yang, S.-H., Yun, Y., Choi, Y., et al. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00817.x · Cited by 100 · see citing works

Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model

Garcia-Alloza, M., Dodwell, S. A., Meyer-Luehmann, M., Hyman, B. T., & Bacskai, B. J. (2006) · Journal of Neuropathology &amp; Experimental Neurology · doi:10.1097/01.jnen.0000240468.12543.af · Cited by 99 · see citing works

Brain membrane fluidity and lipid peroxidation in Alzheimer's disease

Hajimohammadreza, I., & Brammer, M. J. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90226-y · Cited by 96 · see citing works

Interaction between NH2-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration

Amadoro, G., Corsetti, V., Atlante, A., Florenzano, F., Capsoni, S., Bussani, R., Mercanti, D., & Calissano, P. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.08.001 · Cited by 94 · see citing works

A peptide containing residues 26–44 of tau protein impairs mitochondrial oxidative phosphorylation acting at the level of the adenine nucleotide translocator

Atlante, A., Amadoro, G., Bobba, A., Lidia de, B. A. R. I., Corsetti, V., Pappalardo, G., Marra, E., Calissano, P., & Passarella, S. (2008) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2008.07.004 · Cited by 93 · see citing works

Prolonged Exposure of Cortical Neurons to Oligomeric Amyloid-β Impairs NMDA Receptor Function Via NADPH Oxidase-Mediated ROS Production: Protective Effect of Green Tea (-)-Epigallocatechin-3-Gallate

He, Y., Cui, J., Lee, J. C., Ding, S., Chalimoniuk, M., Simonyi, Á., Sun, A. Y., Gu, Z., Weisman, G. A., Wood, W. G., et al. (2011) · ASN NEURO · doi:10.1042/an20100025 · Cited by 92 · see citing works

The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease

Głodzik-Sobańska, L., Pirraglia, E., Bryś, M., Santi, S. D., Mosconi, L., Rich, K. E., Switalski, R., Louis, L. S., Sadowski, M. J., Martiniuk, F. T., et al. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.08.019 · Cited by 90 · see citing works

Effect of energy shortage and oxidative stress on amyloid precursor protein metabolism in COS cells

Gasparini, L., Racchi, M., Benussi, L., Curti, D., Binetti, G., Bianchetti, A., Trabucchi, M., & Govoni, S. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00536-3 · Cited by 89 · see citing works

Proteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: a regional study

Sultana, R., Reed, T., Perluigi, M., Coccia, R., Pierce, W. M., & Butterfield, D. A. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00065.x · Cited by 87 · see citing works

Neurodegenerative diseases: The immunological perspective

Molteni, M., & Rossetti, C. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.11.002 · Cited by 85 · see citing works

High dietary advanced glycation end products are associated with poorer spatial learning and accelerated Aβ deposition in an Alzheimer mouse model

Lubitz, I., Říčný, J., Atrakchi, D., Shemesh, C., Kravitz, E., Zaltsman, S. L., Maksin-Matveev, A., Cooper, I., Leibowitz, A., Uribarri, J., et al. (2016) · Aging Cell · doi:10.1111/acel.12436 · Cited by 84 · see citing works

Coenzyme Q10 protects against amyloid beta-induced neuronal cell death by inhibiting oxidative stress and activating the P13K pathway

Choi, H., Park, H., Koh, S., Choi, N.-Y., Yu, H., Park, J., Lee, Y. J., & Lee, K. (2011) · NeuroToxicology · doi:10.1016/j.neuro.2011.12.005 · Cited by 82 · see citing works

Conformational Altered p53 as an Early Marker of Oxidative Stress in Alzheimer's Disease

Buizza, L., Cenini, G., Lanni, C., Ferrari‐Toninelli, G., Prandelli, C., Govoni, S. M., Buoso, E., Racchi, M., Barcikowska, M., Styczyńska, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029789 · Cited by 81 · see citing works

The Complex Role of Apolipoprotein E in Alzheimer’s Disease: an Overview and Update

Mahoney‐Sanchez, L., Belaidi, A. A., Bush, A. I., & Ayton, S. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0839-z · Cited by 81 · see citing works

Meta‐analysis of randomized, double‐blind, placebo‐controlled trials of melatonin in Alzheimer's disease

Wang, Y. Y., Zheng, W., Ng, C. H., Ungvari, G. S., Wei, W., & Xiang, Y. (2016) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4571 · Cited by 78 · see citing works

Type 2 diabetes is an independent risk factor for dementia conversion in patients with mild cognitive impairment

Ciudin, A., Espinosa, A., Simó‐Servat, O., Ruiz, A., Alegret, M., Hernández, C., Boada, M., & Simó, R. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.04.018 · Cited by 78 · see citing works

Increased Cerebrospinal Fluid F2-Isoprostanes are Associated with Aging and Latent Alzheimer’s Disease as Identified by Biomarkers

Montine, T. J., Peskind, E. R., Quinn, J. F., Wilson, A. M., Montine, K. S., & Galasko, D. R. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8126-6 · Cited by 77 · see citing works

Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the concept

Epelbaum, S., Genthon, R., Cavedo, E., Habert, M. O., Lamari, F., Gagliardi, G. P., Lista, S., Teichmann, M., Bakardjian, H., Hampel, H. J., et al. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.12.003 · Cited by 77 · see citing works

Peripheral Biomarkers of Alzheimer's Disease

Khan, T. K., & Alkon, D. L. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142262 · Cited by 75 · see citing works

Endogenous Aβ causes cell death via early tau hyperphosphorylation

Amadoro, G., Corsetti, V., Ciotti, M. T., Florenzano, F., Capsoni, S., Amato, G., & Calissano, P. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.06.005 · Cited by 73 · see citing works

Cellular stress response, sirtuins and UCP proteins in Alzheimer disease: role of vitagenes

Cornelius, C., Salinaro, A. T., Scuto, M. C., Fronte, V., Cambria, M. T., Pennisi, M., Bella, R., Milone, P., Graziano, A., Crupi, R., et al. (2013) · Immunity & Ageing · doi:10.1186/1742-4933-10-41 · Cited by 73 · see citing works

Idebenone in senile dementia of Alzheimer type: A multicentre study

Senin, U., Parnetti, L., Barbagallo-Sangiorgi, G., Bartorelli, L., Bocola, V., Capurso, A., Cuzzupoli, M., Denaro, M., Marigliano, V., Tammaro, A. E., et al. (1992) · Archives of Gerontology and Geriatrics · doi:10.1016/0167-4943(92)90060-h · Cited by 72 · see citing works

Detection and Localization of Markers of Oxidative Stress by In Situ Methods: Application in the Study of Alzheimer Disease

Moreira, P. I., Sayre, L. M., Zhu, X., Nunomura, A., Smith, M. A., & Perry, G. L. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-029-8_25 · Cited by 66 · see citing works

Modifications of platelet from Alzheimer disease patients: A possible relation between membrane properties and NO metabolites

Vignini, A., Nanetti, L., Moroni, C., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.010 · Cited by 65 · see citing works

Insulin signaling: An opportunistic target to minify the risk of Alzheimer’s disease

Pardeshi, R., Bolshette, N. B., Gadhave, K., Ahire, A., Ahmed, S., Cassano, T., Gupta, V. B., & Lahkar, M. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.05.004 · Cited by 65 · see citing works

Lymphocyte mitochondria: toward identification of peripheral biomarkers in the progression of Alzheimer disease

Sultana, R., Baglioni, M., Cecchetti, R., Cai, J., Klein, J. B., Bastiani, P., Ruggiero, C., Mecocci, P., & Butterfield, D. A. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.08.001 · Cited by 64 · see citing works

Bridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive Potential

de Matos, A. M., de Macedo, M. L. R., & Rauter, A. (2018) · Medicinal research reviews (Print) · doi:10.1002/med.21440 · Cited by 63 · see citing works

The effects of perturbed energy metabolism on the processing of amyloid precursor protein in PC12 cells

Webster, M.-T., Pearce, B. R., Bowen, D. M., & Francis, P. T. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050098 · Cited by 62 · see citing works

Differential expression and redox proteomics analyses of an Alzheimer disease transgenic mouse model: effects of the amyloid-β peptide of amyloid precursor proteinΞ

Robinson, R. A. S., Lange, M. L. B., Rukhsana Sultana, A., Galván, V., Fombonne, J., Gorostiza, O. F., Zhang, J., Warrier, G., Cai, J., Pierce, W. M. J., et al. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.01.005 · Cited by 61 · see citing works

Influence of caloric intake on aging and on the response to stressors

Masoro, E. J. (1998) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937409809524554 · Cited by 60 · see citing works

Ubisol-Q10 (a Nanomicellar Water-Soluble Formulation of CoQ10) Treatment Inhibits Alzheimer-Type Behavioral and Pathological Symptoms in a Double Transgenic Mouse (TgAPEswe, PSEN1dE9) Model of Alzheimer’s Disease

Muthukumaran, K., Kanwar, A. S., Vegh, C., Marginean, A., Elliott, A., Guilbeault, N. C., Badour, A., Sikorska, M., Cohen, J. S., & Pandey, S. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170275 · Cited by 60 · see citing works

Processive proteolysis by γ-secretase and the mechanism of Alzheimer’s disease

Wolfe, M. S. (2012) · Biological Chemistry · doi:10.1515/hsz-2012-0140 · Cited by 59 · see citing works

Oxidative imbalance and cathepsin D changes as peripheral blood biomarkers of Alzheimer disease: A pilot study

Straface, E., Matarrese, P., Gambardella, L., Vona, R., Sgadari, A., Silveri, M. C., & Malorni, W. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.03.094 · Cited by 58 · see citing works

Heme oxygenase-1 induction and mitochondrial iron sequestration in astroglia exposed to amyloid peptides.

Ham, D., & Schipper, H. M. (2000) · PubMed · Cited by 58 · see citing works

Search for Alzheimer's Disease Biomarkers in Blood Cells: Hypotheses-Driven Approach

Wojsiat, J., Laskowska-Kaszub, K., Mietelska‐Porowska, A., & Wojda, U. (2017) · Biomarkers in Medicine · doi:10.2217/bmm-2017-0041 · Cited by 58 · see citing works

A Heme Oxygenase-1 Transducer Model of Degenerative and Developmental Brain Disorders

Schipper, H. M., & Song, W. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16035400 · Cited by 57 · see citing works

Nuclear and mitochondrial DNA oxidation in Alzheimer's disease

Santos, R. X., Correia, S. C., Zhu, X., Lee, H.-G., Petersen, R. B., Nunomura, A., Smith, M. A., Perry, G., & Moreira, P. I. (2012) · Free Radical Research · doi:10.3109/10715762.2011.648188 · Cited by 57 · see citing works

Oxidative Stress and Aberrant Cell Cycle in Alzheimer’s Disease Lymphocytes: Diagnostic Prospects

Wojsiat, J., Prandelli, C., Laskowska-Kaszub, K., Martín‐Requero, Á., & Wojda, U. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141977 · Cited by 55 · see citing works

Characterization of α1-antitrypsin as a heme oxygenase-1 suppressor in Alzheimer plasma

Maes, O. C., Kravitz, S., Mawal, Y. R., Su, H., Liberman, A., Mehindate, K., Berlin, D., Sahlas, D. J., Chertkow, H. M., & Bergman, H. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.06.009 · Cited by 54 · see citing works

Lymphocytic mitochondrial aconitase activity is reduced in Alzheimer’s disease and mild cognitive impairment

Mangialasche, F., Baglioni, M., Cecchetti, R., Kivipelto, M., Ruggiero, C., Piobbico, D., Kussmaul, L., Monastero, R., Brancorsini, S., & Mecocci, P. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142052 · Cited by 53 · see citing works

Expression and Polymorphisms of Gene 8-Oxoguanine Glycosylase 1 and the Level of Oxidative DNA Damage in Peripheral Blood Lymphocytes of Patients with Alzheimer's Disease

Dorszewska, J., Kempisty, B., Jaroszewska-Kolecka, J., Różycka, A., Florczak, J., Lianeri, M., Jagodziński, P. P., & Kozubski, W. P. (2009) · DNA and Cell Biology · doi:10.1089/dna.2009.0926 · Cited by 52 · see citing works

Enhanced ROS-Generation in Lymphocytes from Alzheimer’s Patients

Leutner, S., Schindowski, K., Frölich, L., Maurer, K., Kratzsch, T., Eckert, A., & Müller, W. E. G. (2005) · Pharmacopsychiatry · doi:10.1055/s-2005-916186 · Cited by 50 · see citing works

Presymptomatic Alterations in Energy Metabolism and Oxidative Stress in the APP23 Mouse Model of Alzheimer Disease

Hartl, D., Schuldt, V., Forler, S., Zabel, C., Klose, J., & Rohe, M. (2012) · Journal of Proteome Research · doi:10.1021/pr300021e · Cited by 48 · see citing works

Reductive stress in young healthy individuals at risk of Alzheimer disease

Badía, M.-C., Giraldo, E., Dası́, F., Alonso, D., Lainez, J. M., Lloret, A., & Viña, J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.003 · Cited by 47 · see citing works

Molecular and biochemical trajectories from diabetes to Alzheimer’s disease: A critical appraisal

Sandhir, R., & Gupta, S. N. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i12.1223 · Cited by 47 · see citing works

The Keap1-Nrf2 System: A Mediator between Oxidative Stress and Aging

Yu, C., & Xiao, J.-H. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6635460 · Cited by 537 · see citing works

Western diet as a trigger of Alzheimer’s disease: From metabolic syndrome and systemic inflammation to neuroinflammation and neurodegeneration

Więckowska-Gacek, A., Mietelska-Porowska, A., Wydrych, M., & Wojda, U. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101397 · Cited by 343 · see citing works

Alzheimer’s disease as type 3 diabetes: understanding the link and implications

Kciuk, M., Kruczkowska, W., Gałęziewska, J., Wanke, K., Kałuzińska-Kołat, Ż., Aleksandrowicz, M., & Kontek, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211955 · Cited by 98 · see citing works

Centella Asiatica Improves Memory and Promotes Antioxidative Signaling in 5XFAD Mice

Matthews, D. G., Caruso, M., Murchison, C. F., Zhu, J. Y., Wright, K. M., Harris, C. J., Gray, N. E., Quinn, J. F., & Soumyanath, A. (2019) · Antioxidants · doi:10.3390/antiox8120630 · Cited by 86 · see citing works

Importance of oxidative stress in the pathogenesis, diagnosis, and monitoring of patients with neuropsychiatric disorders, a review

Cecerska-Heryć, E., Polikowska, A., Serwin, N., Roszak, M., Grygorcewicz, B., Heryć, R., Michalczyk, A., & Dołęgowska, B. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2021.105269 · Cited by 68 · see citing works

Mitochondria and Cellular Redox State on the Route from Ageing to Alzheimer's Disease

Abate, G., Vezzoli, M., Sandri, M., Rungratanawanich, W., Memo, M., & Uberti, D. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111385 · Cited by 41 · see citing works

Protein nitration profile of CD3+ lymphocytes from Alzheimer disease patients: Novel hints on immunosenescence and biomarker detection

Tramutola, A., Abate, G., Lanzillotta, C., Triani, F., Barone, E., Iavarone, F., Vincenzoni, F., Castagnola, M., Marziano, M., Memo, M., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.414 · Cited by 26 · see citing works

DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION

Mustafa, N. H., Kelesbayev, D., & Alibekova, Z. D. (2018) · The Journal of Economic Research & Business Administration · doi:10.26577/be-2018-2-2141

Susquehanna Chorale Spring Concert "Roots and Wings"

Hawkins, D. (2017)

Genentech taps Affimed’s antibodies

Cross, R. (2018) · C&EN Global Enterprise · doi:10.1021/cen-09635-buscon15

KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK

Sari, D. (2023) · Jurnal Komplikasi Anestesi · doi:10.22146/jka.v5i1.7322

Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria

Dib, A., Puig, L. B., Salvadori, D., et al. (1988) · Arquivos Brasileiros de Cardiologia